Impact of modulation of the endocannabinoid system on the intestinal microcirculation in experimental sepsis (original) (raw)
Endocannabinoid-mediated modulation of Gq protein-coupled receptor mediates vascular hyporeactivity to nor-adrenaline during polymicrobial sepsis
Soumen Choudhury
Pharmacological reports : PR, 2018
View PDFchevron_right
Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB 1 receptors and fatty acid amide hydrolase
Benedicte De Winter
Neurogastroenterology & Motility, 2008
View PDFchevron_right
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis
Sara Whynot
Critical Care, 2012
View PDFchevron_right
Cannabinoid 2 Receptor and GPR55 as Therapeutic Targets in Experimental Sepsis
Olivia Yang
2017
View PDFchevron_right
Involvement of Central Endothelin ETA and Cannabinoid CB1 Receptors and Arginine Vasopressin Release in Sepsis Induced by Cecal Ligation and Puncture in Rats
Daniel Fraga
Shock, 2016
View PDFchevron_right
Endocannabinoids, Anandamide and 2-Arachidonoylglycerol, as Prognostic Markers of Sepsis Outcome and Complications
Damir Mihić
Cannabis and Cannabinoid Research
View PDFchevron_right
Effects of dopexamine on the intestinal microvascular blood flow and leukocyte activation in a sepsis model in rats
Taras Usichenko
Critical care (London, England), 2006
View PDFchevron_right
Effects of dopexamine on the intestinal microvascular blood flow and leucocyte activation in a sepsis model in rats
Dragan Pavlovic
Critical Care, 2006
View PDFchevron_right
The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract
Beat Lutz
Journal of Molecular Medicine, 2005
View PDFchevron_right
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
Saoirse O'Sullivan
British Journal of Pharmacology, 2012
View PDFchevron_right
The Effects of Tramadol and Fentanyl on Gastrointestinal Motility in Septic Rats
Melek Civi
Anesthesia & Analgesia, 2006
View PDFchevron_right
Endocannabinoids and the gastrointestinal tract: what are the key questions?
G. Sanger
British Journal of Pharmacology, 2009
View PDFchevron_right
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice
Francesca Borrelli, Raffaele Capasso, Anna Costagliola
Gastroenterology, 2003
View PDFchevron_right
Betacaryophyllene - A phytocannabinoid as potential therapeutic modality for human sepsis?
Angel Meza
Medical hypotheses, 2018
View PDFchevron_right
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells
Kayla Sheehan
Journal of Biological Chemistry, 2014
View PDFchevron_right
Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat
Guillermo Fernández
Gastroenterology, 2002
View PDFchevron_right
Ketamine and propofol do not affect intestinal microcirculation in the rat endotoxemia: experiments in a new model for intravital microscopy
Dragan Pavlovic
2005
View PDFchevron_right
Endocannabinoids and the haematological system
Michael Randall
British Journal of Pharmacology, 2009
View PDFchevron_right
The endocannabinoid system and the molecular basis of paralytic ileus in mice
Nicola Mascolo
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002
View PDFchevron_right
Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus
Martin Storr
Neurogastroenterology & Motility, 2010
View PDFchevron_right
Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis
Julian Romero
Liver International, 2004
View PDFchevron_right